Ignite Creation Date:
2024-05-05 @ 4:52 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00331006
Status:
COMPLETED
Last Update Posted:
2013-06-11
First Post:
2006-05-26
Brief Title:
Rituximab to Treat Severe Hemophilia A
Sponsor:
Carelon Research
Organization:
Carelon Research
Organization Data
Organization:
Carelon Research
Class:
OTHER
Study ID:
374
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Carelon Research
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Genentech Inc | INDUSTRY |
| National Heart Lung and Blood Institute NHLBI | NIH |